ReviewCureus2026
Iron Deficiency, Iron Deficiency Anemia, and HbA1c Levels in Nondiabetic Adults: A Systematic Review and Meta-Analysis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iron deficiency refers to depleted body iron stores, while iron deficiency anemia (IDA) develops when iron depletion becomes sufficient to impair hemoglobin production. Both conditions may influence glycated hemoglobin (HbA1c) independently of circulating glucose and may therefore affect glycemic classification in adults without diabetes. This systematic review and meta-analysis evaluated the association of iron deficiency and IDA with HbA1c levels, while also examining anemia severity, iron-status markers, the effects of iron replacement, and the potential for HbA1c-based glycemic misclassification. PubMed/MEDLINE and Scopus were searched from inception to the final search, supplemented by Google Scholar and citation tracking. Eligible observational and before-and-after studies included adults without established diabetes and reported HbA1c in relation to iron status. Two reviewers independently performed study screening and data extraction. Risk of bias was assessed using Joanna Briggs Institute tools appropriate to each analytical component. Twenty-five reports were included, representing 24 independent populations. The primary meta-analysis did not establish a conclusive overall difference in HbA1c between participants with IDA and non-anemic controls, while the expanded sensitivity analysis suggested higher HbA1c in IDA but remained affected by substantial heterogeneity and methodological limitations. Individual studies reported inconsistent relationships between HbA1c, anemia severity, and iron-status markers. Most iron-treatment studies reported reductions in HbA1c after treatment, although some reported increases, and incomplete paired-data reporting prevented valid pooling. Evidence also suggested that IDA may contribute to HbA1c-based glycemic misclassification, particularly near diagnostic thresholds. Overall, the available evidence indicates that iron deficiency and IDA may affect HbA1c in adults without diabetes, although the direction and magnitude of this effect remain inconsistent. Accordingly, HbA1c warrants cautious interpretation when iron deficiency or anemia is present, especially when it is discordant with glucose-based testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.